Belantamab Mafodotin in Combination with Lenalidomide Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Safety and Efficacy Analysis of DREAMM-6 Trial Arm-a

Introduction: Belantamab mafodotin (belamaf) is a first-in-class, antibody-drug conjugate that targets B-cell maturation antigen. In the recent ALGONQUIN study, clinical activity associated with belamaf in combination with the immunomodulatory drug pomalidomide were increased in triple-class exposed...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.2010-2010
Hauptverfasser:	Popat, Rakesh, Augustson, Bradley, Gironella, Mercedes, Lee, Cindy, Cannell, Paul, Patel, Nashita, Kasinathan, Ravi, Rogers, Rachel, Curry, Amy, Carreno, Fernando, Roy-Ghanta, Sumita, Opalinska, Joanna, Quach, Hang
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!